Hjem › Metastatisk kreft › New Mexico › Albuquerque
Kliniske studier for Metastatisk kreft i Albuquerque, NM
12 studier for Metastatisk kreft søker deltakere på steder i og rundt Albuquerque (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- University of New Mexico Cancer Center, Albuquerque
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruttererFase 2/3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Albuquerque
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekruttererFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
RekruttererObservasjonsstudie
- New Mexico Oncology Hematology Consultants, Albuquerque
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Optimum Clinical Research Group, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruttererFase 3
- Research Site, Albuquerque
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
RekruttererFase 1
- New Mexico Oncology Hematology Consultants Ltd, Albuquerque
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekruttererFase 1/2
- Presbyterian Kaseman Hospital (site 208), Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Albuquerque
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Albuquerque
- Ikke-småcellet lungekreft18 studier
- Brystkreft17 studier
- Eggstokkreft15 studier
- Kreft (alle typer)14 studier
- Lungekreft14 studier
- Endometriekreft12 studier
- Type 2-diabetes11 studier
- Kardiovaskulær sykdom10 studier
- Melanom9 studier
- Akut myelogen leukemi9 studier
- Prostatakreft9 studier
- Kronisk nyresykdom8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.